[go: up one dir, main page]

TW200635600A - Tetracyclic bicyclolides - Google Patents

Tetracyclic bicyclolides

Info

Publication number
TW200635600A
TW200635600A TW094144052A TW94144052A TW200635600A TW 200635600 A TW200635600 A TW 200635600A TW 094144052 A TW094144052 A TW 094144052A TW 94144052 A TW94144052 A TW 94144052A TW 200635600 A TW200635600 A TW 200635600A
Authority
TW
Taiwan
Prior art keywords
present
compounds
subject
bicyclolides
tetracyclic
Prior art date
Application number
TW094144052A
Other languages
English (en)
Inventor
Da-Tong Tang
Yong-Hua Gai
Ying Sun
Yat-Sun Or
Zhe Wang
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Publication of TW200635600A publication Critical patent/TW200635600A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW094144052A 2004-12-13 2005-12-13 Tetracyclic bicyclolides TW200635600A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63565004P 2004-12-13 2004-12-13

Publications (1)

Publication Number Publication Date
TW200635600A true TW200635600A (en) 2006-10-16

Family

ID=36588440

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094144052A TW200635600A (en) 2004-12-13 2005-12-13 Tetracyclic bicyclolides

Country Status (3)

Country Link
US (1) US7312201B2 (zh)
TW (1) TW200635600A (zh)
WO (1) WO2006065743A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1836211T3 (pl) 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
DK1934238T3 (en) 2005-08-24 2017-09-18 Melinta Therapeutics Inc TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE
US7407942B2 (en) * 2006-03-29 2008-08-05 Emata Pharmaceuticals, Inc 3,6-bridged 9,12-oxolides
AU2007256844A1 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
WO2009064953A1 (en) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096969C (en) 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
KR0166996B1 (ko) 1992-04-22 1999-01-15 우에하라 아키라 5-o-데소사미닐에리쓰로노라이드a 유도체
FR2738571B1 (fr) 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
ES2242983T3 (es) * 1996-09-04 2005-11-16 Abbott Laboratories Cetolidos 6-0-sustituidos que tienen una actividad antibacteriana.
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
CA2483678C (en) 2002-05-13 2010-01-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
WO2003095466A1 (en) 2002-05-13 2003-11-20 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US7402568B2 (en) * 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives

Also Published As

Publication number Publication date
US20060142215A1 (en) 2006-06-29
US7312201B2 (en) 2007-12-25
WO2006065743A2 (en) 2006-06-22
WO2006065743A3 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
TWI327573B (en) 6-11 bicyclic ketolide derivatives
WO2008154642A3 (en) Antibacterial agents
WO2005000863A3 (en) 6, 11-4c-bicyclic 9a-azalide derivatives
WO2004062601A3 (en) Antibacterial agents
WO2004087728A3 (en) 6,11-3c-bicyclic 9a-azalide derivatives
UA94901C2 (ru) Антибактериальные производные пиперидина
MX2009005603A (es) Compuestos de urea policiclicos antibacterianos.
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
WO2004096823A3 (en) Novel ketolide derivatives
UA101305C2 (ru) Антибактериальные производные хинолина
TW200634021A (en) 3,6-bicyclolides
CA2483875A1 (en) 6,11 bicyclic erythromycin derivatives
WO2005070113A3 (en) 9n-substituted 6-11 bicyclic erythromycin derivatives
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TW200806321A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
JO2725B1 (en) Quinoline antibacterial derivatives
WO2006065721A3 (en) 11, 12-lactone bicyclolides
WO2005067564A3 (en) 6-11 bicyclic erythromycin derivatives
TW200635600A (en) Tetracyclic bicyclolides
WO2007044927A3 (en) 6, 11-bridged tricyclic macrolides
JO2970B1 (en) Quinoline antibacterial derivatives
WO2008014221A3 (en) Bridged carbamate macrolides